Delivery Order SPE2DB22D9143-SPE2DB25FZC90
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,286.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of LENVIMA 8 mg daily dose medication in 60-count units. The delivery order, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, operates under a firm fixed-price contract type with no set-aside designation. This award is issued as a delivery order under DMS...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose (60-count). The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 14 mg daily dose medication (60-count supply). This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, represents a tactical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $11,353.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 18, 2025, for the supply of Lenvima 20 mg daily dose (60-count packages). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with an ultimate completion date of October 9, 2025. The contract carries no set-aside designation, allowing the vendor to compete...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 12 mg daily dose in 90-count quantities. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed-price terms without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 8 mg daily dose tablets (60-count supply) with a ceiling value of $11,353.77. This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a procurement of a specialized oncology medication. The contract carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,006.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a prescription medication, with a period of performance through August 5, 2024. This delivery order contract was issued under DMS Pharmaceutical Group's existing, single-award indefinite delivery contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $34,061.31 to DMS Pharmaceutical Group Inc. for the supply of Lenvima 8 mg daily dose tablets (60-count). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of October 6, 2025. This award was made without a set-aside designation, and the contract was...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- SPE2DB22D9143Indefinite Delivery Contract
- SPE2DB22D9143-SPE2DB25FZC90Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 20 MG daily dose medication (60-count supply). The contract was awarded on September 29, 2025, with an ultimate completion date of October 21, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities. DMS Pharmaceutical Group leverages its position as an established pharmaceutical distributor to the federal government, having served as a prime contractor on the Defense Logistics Agency's SPE2DB program since its registration in SAM.gov in 2001. The company maintains a robust portfolio of delivery orders covering prescription medications, biologics, over-the-counter products, and specialty pharmaceuticals distributed to military health facilities nationwide. This award of LENVIMA, an oncology therapeutic, reflects the company's ongoing role as a critical supplier in the federal pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/29/25 |